Ferring Pharmaceuticals Inc Recalls

All product recalls associated with Ferring Pharmaceuticals Inc.

Get alerts for this brand

Recall Summary

Total Recalls

12

Past Year

0

Class I (Serious)

3

Most Recent

Jun 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–12 of 12 recalls

Endometrin Vaginal Insert (Ferring) – Microbial Contamination Risk (2023)

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Class IIModerate

FDAJun 12, 2023Nationwide• Ferring Pharmaceuticals Inc

ZOMA-Jet 5 Demonstration Kit (Ferring) – Injector Defect (2021)

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Class IIModerate

FDAMar 11, 2021Nationwide• Ferring Pharmaceuticals Inc

ZOMA-Jet 10 Demonstration Kit (Ferring) – Injector Defect (2021)

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Class II

Moderate

FDAMar 11, 2021Nationwide• Ferring Pharmaceuticals Inc

Menopur (Ferring) – pH specification failure (2021)

Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP

Class IIILow

FDAMar 2, 2021Nationwide• Ferring Pharmaceuticals Inc

STIMATE Nasal Spray (Ferring) – Superpotent Drug (2020)

Superpotent Drug

Class IHigh

FDAJul 21, 2020Nationwide• Ferring Pharmaceuticals Inc

Desmopressin Acetate Nasal Spray (Ferring) – Superpotent Drug (2020)

Superpotent Drug

Class IHigh

FDAJul 21, 2020Nationwide• Ferring Pharmaceuticals Inc

DDAVP Nasal Spray (Ferring) – Superpotent Drug (2020)

Superpotent Drug

Class IHigh

FDAJul 21, 2020Nationwide• Ferring Pharmaceuticals Inc

Bravelle (Ferring Pharmaceuticals) – subpotent drug (2015)

Subpotent Drug

Class IIILow

FDASep 9, 2015Nationwide• Ferring Pharmaceuticals Inc

TEV-TROPIN Injection (Ferring) – Silicone Oil Contamination (2014)

Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.

Class IIModerate

FDAApr 28, 2014PA• Ferring Pharmaceuticals Inc

Endometrin Vaginal Insert (Ferring) – Heat Discoloration (2013)

Discoloration; due to prolonged heat exposure.

Class IIILow

FDASep 19, 2013Nationwide• Ferring Pharmaceuticals Inc

TEV-TROPIN Injection (Ferring) – Label Mix-up (2013)

Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A

Class IIILow

FDAFeb 1, 2013Nationwide• Ferring Pharmaceuticals Inc

Novarel Chorionic Gonadotropin (Ferring Pharmaceuticals) – Labeling omission (2012)

Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.

Class IIILow

FDAAug 23, 2012Nationwide• Ferring Pharmaceuticals Inc

Stay Informed

Ferring Pharmaceuticals Inc Recalls

Recall Summary

Endometrin Vaginal Insert (Ferring) – Microbial Contamination Risk (2023)

ZOMA-Jet 5 Demonstration Kit (Ferring) – Injector Defect (2021)

ZOMA-Jet 10 Demonstration Kit (Ferring) – Injector Defect (2021)

Menopur (Ferring) – pH specification failure (2021)

STIMATE Nasal Spray (Ferring) – Superpotent Drug (2020)

Desmopressin Acetate Nasal Spray (Ferring) – Superpotent Drug (2020)

DDAVP Nasal Spray (Ferring) – Superpotent Drug (2020)

Bravelle (Ferring Pharmaceuticals) – subpotent drug (2015)

TEV-TROPIN Injection (Ferring) – Silicone Oil Contamination (2014)

Endometrin Vaginal Insert (Ferring) – Heat Discoloration (2013)

TEV-TROPIN Injection (Ferring) – Label Mix-up (2013)

Novarel Chorionic Gonadotropin (Ferring Pharmaceuticals) – Labeling omission (2012)